Trial Profile
Evaluation of Clevidipine in the Perioperative Treatment of Hypertension Assessing Safety Events (With Nitroglycerin as Active Comparator) (ECLIPSE-NTG)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 19 Jun 2014
Price :
$35
*
At a glance
- Drugs Clevidipine (Primary) ; Nitroglycerin
- Indications Cardiovascular disorders; Hypertension; Perioperative hypertension
- Focus Registrational; Therapeutic Use
- Acronyms ECLIPSE-NTG
- Sponsors The Medicines Company
- 13 Sep 2006 Status change
- 08 Oct 2005 New trial record.